These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37533083)

  • 21. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.
    Yang C; Wan M; Xu D; Pan D; Xia H; Yang L; Sun G
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-κB/CCL3/CCR1 axis.
    Tan YY; Yue SR; Lu AP; Zhang L; Ji G; Liu BC; Wang RR
    Phytomedicine; 2022 Aug; 103():154208. PubMed ID: 35691078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
    Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
    J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spermidine Ameliorates Nonalcoholic Steatohepatitis through Thyroid Hormone-Responsive Protein Signaling and the Gut Microbiota-Mediated Metabolism of Bile Acids.
    Ni Y; Hu Y; Lou X; Rong N; Liu F; Yang C; Zheng A; Yang S; Bao J; Fu Z
    J Agric Food Chem; 2022 Jun; 70(21):6478-6492. PubMed ID: 35583480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3.
    Lin YP; Fang QL; Xue YM; Fu SN; Hu CY; Huang F; Wang MM; Qiao X; Yin XQ; Zeng YC; Du CH; Zhao XJ; Li XP; Hua Y
    J Ethnopharmacol; 2023 Apr; 305():116145. PubMed ID: 36623753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis.
    Li H; Wang M; Chen P; Zhu M; Chen L
    Biomed Pharmacother; 2024 May; 174():116617. PubMed ID: 38643542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
    Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
    Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
    Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
    Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal obesogenic diet regulates offspring bile acid homeostasis and hepatic lipid metabolism via the gut microbiome in mice.
    Thompson MD; Kang J; Faerber A; Hinrichs H; Özler O; Cowen J; Xie Y; Tarr PI; Davidson NO
    Am J Physiol Gastrointest Liver Physiol; 2022 Mar; 322(3):G295-G309. PubMed ID: 34984925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin.
    Zeng Y; Hua YQ; Wang W; Zhang H; Xu XL
    Biochem Pharmacol; 2020 May; 175():113927. PubMed ID: 32217100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation.
    Yan M; Man S; Liang Y; Ma L; Guo L; Huang L; Gao W
    Pharmacol Res; 2023 Jan; 187():106621. PubMed ID: 36535571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.
    Lv S; Zhang Z; Su X; Li W; Wang X; Pan B; Li H; Zhang H; Wang Y
    Front Endocrinol (Lausanne); 2022; 13():1106875. PubMed ID: 36743916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model.
    Okubo H; Nakatsu Y; Sakoda H; Kushiyama A; Fujishiro M; Fukushima T; Matsunaga Y; Ohno H; Yoneda M; Kamata H; Shinjo T; Iwashita M; Nishimura F; Asano T
    Am J Physiol Gastrointest Liver Physiol; 2015 Jan; 308(2):G151-8. PubMed ID: 25428903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis.
    Schneider KM; Mohs A; Kilic K; Candels LS; Elfers C; Bennek E; Schneider LB; Heymann F; Gassler N; Penders J; Trautwein C
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice.
    Takahashi S; Luo Y; Ranjit S; Xie C; Libby AE; Orlicky DJ; Dvornikov A; Wang XX; Myakala K; Jones BA; Bhasin K; Wang D; McManaman JL; Krausz KW; Gratton E; Ir D; Robertson CE; Frank DN; Gonzalez FJ; Levi M
    J Biol Chem; 2020 Apr; 295(14):4733-4747. PubMed ID: 32075905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis.
    Tanaka N; Matsubara T; Krausz KW; Patterson AD; Gonzalez FJ
    Hepatology; 2012 Jul; 56(1):118-29. PubMed ID: 22290395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis.
    Xie G; Wang X; Huang F; Zhao A; Chen W; Yan J; Zhang Y; Lei S; Ge K; Zheng X; Liu J; Su M; Liu P; Jia W
    Int J Cancer; 2016 Oct; 139(8):1764-75. PubMed ID: 27273788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.